2020

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 17 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 11,500,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

OTHERS Reseller Agreement between EYRIS Pte Ltd, a subsidiary of Nova MSC Berhad, and Topcon Healthcare Solutions Asia Pte Ltd

NOVA MSC BERHAD 12 Nov 2020   INTRODUCTION The Board of Directors of Nova MSC Berhad (“NOVAMSC”) is pleased to announce that the Company’s subsidiary, EYRIS Pte Ltd (“EYRIS”) has signed a Reseller Agreement (“RA”) with Topcon Healthcare Solutions Asia Pte Ltd (“Topcon”) today. The press release in respect of the above is also attached herewith for information.   INFORMATION…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 12 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 200,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

EYRIS PARTNERS TOPCON HEALTHCARE SOLUTIONS TO ROLL OUT SELENA+ IN HARMONY RS FOR 18 ASIAN COUNTRIES

Singapore (9 Nov, 2020) – Topcon Healthcare Solutions Asia Pacific, the leading Japanese ophthalmic solution provider, has inked an agreement with Singapore based EyRIS Private Limited to bring EyRIS SELENA+ to Harmony’s users in 18 countries in South and South East Asia. SELENA+ is a deep learning system (DLS) that can detect 3 eye diseases – diabetic retinopathy, glaucoma suspect…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 04 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 350,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 02 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,390,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Oct
2020

SELENA+ RECEIVES REGULATORY APPROVAL IN BRAZIL

Oct 2020 – SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil. Brazil is one of the 20 countries of the International Diabetes Federation (IDF)…

Read more

Oct
2020

EYRIS NAMED IN “50 INNOVATIVE COMPANIES TO WATCH 2020” LIST

Oct 2020 – EyRIS was named on the list “50 INNOVATIVE COMPANIES TO WATCH 2020” compiled by The Silicon Review. The list recognizes companies that have come up with transformative innovations that deliver a fundamental shift to a new way of doing things. EyRIS stands out amongst AI companies in the healthcare sector for developing SELENA+, an AI Deep Learning…

Read more

Oct
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 27 Oct 2020   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 12,500,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$)…

Read more

Oct
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 26 Oct 2020   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,195,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$)…

Read more

Oct
2020

PROF WONG TIEN YIN, EYRIS CO-FOUNDER ELECTED INTO US NATIONAL ACADEMY OF MEDICINE

Oct 2020 – Every year, the US National Academy of Medicine welcomes 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honours in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. It fills us with pride to…

Read more

Oct
2020

FIRST EYE CENTRE IN MALAYSIA TO UTILISE ARTIFICIAL INTELLIGENCE (AI) FOR RETINAL DISEASE DETECTION

Oct 2020 –  According to the International Diabetes Federation, there are just below 1.8 million undiagnosed diabetics in Malaysia. It is estimated that 17 out of every 100 in Malaysia is suffering from this chronic yet silent condition. One of the most common complication from diabetes is diabetic retinopathy which is asymptomatic during early stages but can lead to blindness…

Read more